» Articles » PMID: 15576484

Antagonism of RAGE Suppresses Peripheral Nerve Regeneration

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2004 Dec 4
PMID 15576484
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Axotomy of peripheral nerve triggers events that coordinate a limited inflammatory response to axonal degeneration and initiation of neurite outgrowth. Inflammatory and neurite outgrowth-promoting roles for the receptor for advanced glycation end products (RAGE) have been suggested, so we tested its role in peripheral nerve regeneration. Analysis of immunohistochemical localization of RAGE by confocal microscopy revealed that RAGE was expressed in axons and infiltrating mononuclear phagocytes upon unilateral sciatic nerve crush in mice. Administration of soluble RAGE, the extracellular ligand binding domain of RAGE, or blocking F(ab')2 fragments of antibodies raised to either RAGE or its ligands, S100/calgranulins or amphoterin, reduced functional recovery as assessed by motor and sensory nerve conduction velocities and sciatic functional index and reduced regeneration, as assessed by myelinated fiber density after acute crush of the sciatic nerve. In parallel, in mice subjected to RAGE blockade, decreased numbers of mononuclear phagocytes infiltrated the distal nerve segments after crush. These findings provide the first evidence of an innate function of the ligand/RAGE axis and suggest that RAGE plays an important role in regeneration of the peripheral nervous system.

Citing Articles

Diabetic Polyneuropathy: New Strategies to Target Sensory Neurons in Dorsal Root Ganglia.

Miyashita A, Kobayashi M, Yokota T, Zochodne D Int J Mol Sci. 2023; 24(6).

PMID: 36983051 PMC: 10051459. DOI: 10.3390/ijms24065977.


Increased cerebrospinal fluid S100B protein levels in patients with trigeminal neuralgia and hemifacial spasm.

Ito E, Seki Y, Saito K, Saito R Acta Neurochir (Wien). 2022; 165(4):959-965.

PMID: 36459237 DOI: 10.1007/s00701-022-05434-0.


Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions.

Koerich S, Parreira G, de Almeida D, Vieira R, de Oliveira A Curr Neuropharmacol. 2022; 21(2):219-234.

PMID: 36154605 PMC: 10190138. DOI: 10.2174/1570159X20666220922153903.


Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration.

Kinscherf N, Pehar M Curr Drug Targets. 2022; 23(12):1191-1209.

PMID: 35702767 PMC: 9589927. DOI: 10.2174/1389450123666220610171005.


Nonoxid-HMGB1 Attenuates Cognitive Impairment After Traumatic Brain Injury in Rats.

Chen J, Gao S, Luo L, Jiang Z, Liang C, He H Front Med (Lausanne). 2022; 9:827585.

PMID: 35479959 PMC: 9035677. DOI: 10.3389/fmed.2022.827585.